… Moreover, outcome definition is a difficult task in SLE trials, with some being too strict or
requiring a long observation period (such as the time to renal failure and need for substitutive …

… take long-term statin treatment is rhabdomyolysis—injury to skeletal muscle cells leading to
leak of myoglobin into the circulation and risk of acute kidney failure. An SNP with population …

… ) as well as cumulative perspective from our discussion with other … in hereditary and
glomerular kidney diseases. Data on … to our understanding of kidney diseases made possible by …

… of new tools, medications, or technology of precision medicine. Thus, we need such a futuristic
approach. In this paper, we provide insights into the renal perspective of future medicine, …

… Owing to such late referral and the limitations of noninvasive diagnostic tools, the cause of
kidney failure is classified as unknown in more than one in ten patients with ESRD 16,17,18 . …

… of personalized medicine and its implementation in various diseases like lung cancer, renal
… personalized medicine and the challenges faced during the data collection, development of …

… New clinical trial design should therefore be considered that … according the concept of
personalized medicine. This has the … provided important insights to apply personalized medicine …

… Sirolimus is now being investigated as a potential treatment for autosomal dominant polycystic
kidney disease (ADPKD), the most common hereditary cause of end-stage renal disease. …

… treatment, end-stage renal failure is … to personalized medicine (Figure 2). This will obviously
require the ability to identify specific subtypes of diabetic kidney disease, and that treatment …